SCHEMBL6091841

SCHEMBL6091841

COc1ccc(-c2cccs2)cc1CC(=O)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
ABCC1 P33527 1/20 0.47
TNFRSF1A P19438 9/20 0.46
ALDH1A1 P00352 3/20 0.46
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
KDM4E B2RXH2 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAPT P10636 2/20 0.43
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
LMNA P02545 1/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6112205 0.87 ABCB1 (0.44) ABCB1NPC1RAB9ASMN1; SMN2ABCC1
SCHEMBL6091940 0.86 TNFRSF1A (0.52) TNFRSF1AALDH1A1MEN1KMT2AKDM4E
SCHEMBL6092780 0.86 TNFRSF1A (0.50) TNFRSF1AALDH1A1MEN1KMT2AKDM4E
SCHEMBL6092548 0.85 KDM4E (0.50) NPC1RAB9ATNFRSF1AALDH1A1MEN1
SCHEMBL6091870 0.85 TNFRSF1A (0.52) TNFRSF1AALDH1A1MEN1KMT2AKDM4E
SCHEMBL6091629 0.85 TNFRSF1A (0.49) TNFRSF1AALDH1A1MEN1KMT2AKDM4E
SCHEMBL6091875 0.85 TNFRSF1A (0.53) TNFRSF1AALDH1A1MEN1KMT2AKDM4E
SCHEMBL6091933 0.84 ALDH1A1 (0.49) TNFRSF1AALDH1A1MEN1KMT2AKDM4E
SCHEMBL6091397 0.84 KDM4E (0.49) TNFRSF1AALDH1A1MEN1KMT2AKDM4E
SCHEMBL6093079 0.81 ABCB1 (0.48) ABCB1NPC1RAB9ASMN1; SMN2ABCC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060063828-A1 1,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof ATHEROGENICS, INC. 2006-03-23 US disclosed
WO-2006004903-A2 1,2-BIS-(SUBSTITUTED-PHENYL)-2-PROPEN-1-ONES AND PHARMACEUTICAL COMPOSITIONS THEREOF ATHEROGENICS, INC. (US) 2006-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063828-A1 1,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof ABCB11, CEL, CYP46A1 ABCB1 26/4885NPC1 95/4885RAB9A 2477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.